The SPARC lentiviral core facility provides production of small scale lentiviral stocks containing shRNA or cDNA for your gene(s) of interest, as well as lentiviral concentration, titrations and transductions. To ensure the compliance with biosafety containment required for lentiviral-based research, SPARC uses the Dharmacon TransLenti™ Viral GPIZ Packaging System.The facility will construct individual lentiviral constructs from template cDNA in our set of lentiviral vectors or shRNA from our extensive on-site pGIPZ human and mouse shRNA libraries.
